[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Page S6344]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3342. Mr. BRAUN submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   ESTABLISHING TRANSPARENCY AROUND PHARMACY 
                   BENEFIT MANAGERS (PBMS) AND PROHIBITING ANTI-
                   COMPETITIVE PBM PRACTICES WITH RESPECT TO 
                   MEDICARE PART D.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     establishing transparency around pharmacy benefit managers 
     (PBMs) and prohibiting anti-competitive PBM practices with 
     respect to Medicare part D, by the amounts provided in such 
     legislation for those purposes, provided that such 
     legislation would not increase the deficit over either the 
     period of the total of fiscal years 2022 through 2026 or the 
     period of the total of fiscal years 2022 through 2031.
                                 ______